Valery Ilinsky

Valery Ilinsky is a visionary leader with over 13 years of experience in human genetics, currently serving as the CEO and founder of Eligens, a pioneering company at the intersection of biotechnology and digital health.

Prior to founding Eligens, Valery Ilinsky successfully led Genotek as its CEO, contributing to the growth and impact of the company in the field of human genetics.

Valery Ilinsky holds a Master's degree in Biochemistry from Lomonosov Moscow State University (MSU) and has completed internships at The George Washington University and University of Zurich, focusing on infectious diseases, tropical medicine, and cancer research.

With a strong passion for healthcare and medical research, Valery Ilinsky has a proven track record of strategic planning, operational excellence, and innovative solutions in personalized healthcare challenges.

Valery Ilinsky's contributions extend to the scientific community through publications in renowned journals such as Nature, The Lancet EClinicalMedicine, and Scientific Reports, reflecting expertise and significant contributions to the field.